Conditions of MTC in sufferers handled with liraglutide, Yet another GLP-1 receptor agonist, are reported during the postmarketing period of time; the data in these studies are inadequate to determine or exclude a causal partnership among MTC and GLP-1 receptor agonist use in individuals. There a